Published in J Gastroenterol on March 29, 2008
Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol (2003) 2.04
Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis. Am J Gastroenterol (2006) 1.69
Neuropsychological impairment in patients with chronic hepatitis C. Hepatology (2002) 1.62
Mental status impairment in patients with West Haven grade zero hepatic encephalopathy: the role of HCV infection. J Gastroenterol (2007) 1.56
Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J Hepatol (2000) 1.40
Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J Int Neuropsychol Soc (2003) 1.39
Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis. Liver Int (2007) 1.06
Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing. J Hepatol (2011) 4.14
The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology (2011) 2.42
Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial. Am J Gastroenterol (2010) 2.30
Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology (2010) 2.28
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet (2013) 1.83
Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis. Dig Liver Dis (2011) 1.68
Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation. Hepatology (2006) 1.66
Factors related to fatigue in patients with cirrhosis before and after liver transplantation. Clin Gastroenterol Hepatol (2011) 1.53
Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology (2010) 1.51
Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet (2010) 1.43
EUS-guided drainage is more successful in pancreatic pseudocysts compared with abscesses. World J Gastroenterol (2011) 1.32
Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci. J Hepatol (2012) 1.29
Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4. Hepatology (2013) 1.11
Drug-induced liver injury: a clinical update. Curr Opin Gastroenterol (2010) 1.10
Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden. Hepatology (2010) 1.09
Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9. Hepatology (2011) 1.09
Gastrointestinal symptoms in patients with liver cirrhosis: associations with nutritional status and health-related quality of life. Scand J Gastroenterol (2006) 1.09
Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis. Liver Int (2007) 1.06
Lower gastrointestinal bleeding: incidence, etiology, and outcomes in a population-based setting. Eur J Gastroenterol Hepatol (2013) 1.05
Health-related quality of life in patients with different stages of liver disease induced by hepatitis C. Scand J Gastroenterol (2009) 1.05
The AST/ALT ratio as an indicator of cirrhosis in patients with PBC. Liver Int (2006) 1.05
Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials. Am J Gastroenterol (2011) 1.03
Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience. Liver Int (2008) 1.00
Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort. Liver Int (2011) 0.99
Increased risk for malignant neoplasms among patients with cirrhosis. Clin Gastroenterol Hepatol (2010) 0.98
High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis. Eur J Intern Med (2008) 0.98
A review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD). Ther Clin Risk Manag (2007) 0.94
Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study. Scand J Gastroenterol (2008) 0.94
The relationship between symptoms, body mass index, gastrointestinal transit and stool frequency in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol (2010) 0.93
NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients. World J Gastroenterol (2013) 0.91
Coronary artery disease in patients with liver cirrhosis. Dig Dis Sci (2009) 0.91
Gut transit is associated with gastrointestinal symptoms and gut hormone profile in patients with cirrhosis. Clin Gastroenterol Hepatol (2008) 0.89
Cholangiocarcinoma or IgG4-associated cholangitis: how feasible it is to avoid unnecessary surgical interventions? Ann Surg (2012) 0.89
Upper gastrointestinal bleeding: incidence, etiology and outcomes in a population-based setting. Scand J Gastroenterol (2013) 0.88
Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response. Scand J Gastroenterol (2010) 0.87
Pregabalin as a probable cause of acute liver injury. Eur J Gastroenterol Hepatol (2008) 0.86
Liver cirrhosis in Iceland and Sweden: incidence, aetiology and outcomes. Scand J Gastroenterol (2009) 0.85
Factors that reduce health-related quality of life in patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol (2012) 0.85
Healthcare-associated and nosocomial bacterial infections in cirrhosis: predictors and impact on outcome. Liver Int (2014) 0.84
Type and etiology of liver cirrhosis are not related to the presence of hepatic encephalopathy or health-related quality of life: a cross-sectional study. BMC Gastroenterol (2008) 0.84
Dominant strictures in patients with primary sclerosing cholangitis-revisited. Am J Gastroenterol (2004) 0.84
Intestinal permeability in cirrhotic patients with and without ascites. Scand J Gastroenterol (2006) 0.84
Characterisation and utility of thiopurine methyltransferase and thiopurine metabolite measurements in autoimmune hepatitis. J Hepatol (2009) 0.83
Inadequate use of proton-pump inhibitors in patients with liver cirrhosis. Eur J Gastroenterol Hepatol (2008) 0.83
Altered postprandial glucose, insulin, leptin, and ghrelin in liver cirrhosis: correlations with energy intake and resting energy expenditure. Am J Clin Nutr (2007) 0.83
Portal vein cannulation: an uncommon complication of endoscopic retrograde cholangiopancreatography. World J Gastroenterol (2011) 0.82
Hepatic encephalopathy in patients with liver cirrhosis: is there a role of malnutrition? World J Gastroenterol (2008) 0.82
Lactulose treatment for hepatic encephalopathy, gastrointestinal symptoms, and health-related quality of life. Hepatology (2007) 0.82
Role of gastric sensorimotor dysfunction in gastrointestinal symptoms and energy intake in liver cirrhosis. Scand J Gastroenterol (2007) 0.81
Prevalence of gastrointestinal symptoms in patients with chronic obstructive pulmonary disease. Eur J Gastroenterol Hepatol (2008) 0.81
Pancreatic metastasis of thymic neuroendocrine carcinoma: is there a role for endoscopic ultrasound?: report of a case and review of the literature. Pancreas (2009) 0.81
Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long-term follow-up in 473 Swedish patients. J Hepatol (2008) 0.81
Intraductal papillary mucinous neoplasm in chronic calcifying pancreatitis: egg or hen? World J Gastroenterol (2009) 0.81
Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease. Liver Int (2014) 0.81
Validation of the Swedish version of the chronic liver disease questionnaire. Scand J Gastroenterol (2012) 0.80
Autoimmune hepatitis among fertile women: strategies during pregnancy and breastfeeding? Scand J Gastroenterol (2007) 0.80
Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure. Scand J Gastroenterol (2015) 0.79
Renal function and cognitive impairment in patients with liver cirrhosis. Scand J Gastroenterol (2007) 0.79
Hepatic encephalopathy is related to anemia and fat-free mass depletion in liver transplant candidates with cirrhosis. Scand J Gastroenterol (2013) 0.79
Pre-transplant renal impairment predicts posttransplant cardiac events in patients with liver cirrhosis. Transplantation (2014) 0.79
Fatigue measurements in patients with primary biliary cirrhosis and the risk of mortality during follow-up. Liver Int (2009) 0.79
Transitions between variant forms of primary biliary cirrhosis during long-term follow-up. Eur J Intern Med (2009) 0.79
Long-term follow-up of patients with acute liver failure of indeterminate aetiology. Scand J Gastroenterol (2008) 0.78
Recurrent acute pancreatitis as primary manifestation of gangliocytic paraganglioma of the ampulla. Pancreas (2011) 0.78
Pharmacokinetic study of esomeprazole in patients with hepatic impairment. Eur J Gastroenterol Hepatol (2002) 0.78
Impact of peri-transplant heart failure & left-ventricular diastolic dysfunction on outcomes following liver transplantation. Liver Int (2012) 0.78
Adenocarcinoma of the ampulla of Vater: does the histopathologic type matter? Scand J Gastroenterol (2011) 0.78
Abstinence in patients with alcoholic liver cirrhosis: A follow-up study. Hepatol Res (2008) 0.78
Prevalence of pre-transplant electrocardiographic abnormalities and post-transplant cardiac events in patients with liver cirrhosis. BMC Gastroenterol (2014) 0.78
Natural history of irritable bowel syndrome in women and dysmenorrhea: a 10-year follow-up study. Gastroenterol Res Pract (2012) 0.78
Severe injury to the small bowel associated with a short course of diclofenac. Scand J Gastroenterol (2008) 0.78
Gastrointestinal symptoms in patients with cirrhosis: a longitudinal study before and after liver transplantation. Scand J Gastroenterol (2013) 0.77
Addition of senna improves quality of colonoscopy preparation with magnesium citrate. World J Gastroenterol (2009) 0.77
Acute Pancreatitis and Use of Pancreatitis-Associated Drugs: A 10-Year Population-Based Cohort Study. Pancreas (2015) 0.77
Outcome of patients with primary sclerosing cholangitis and ulcerative colitis undergoing colectomy. World J Gastrointest Pharmacol Ther (2013) 0.77
Emergency readmission following acute upper gastrointestinal bleeding. Eur J Gastroenterol Hepatol (2017) 0.77
Coronary artery disease in liver cirrhosis: does the aetiology of liver disease matter? J Hepatol (2009) 0.76
Cystic neuroendocrine tumor in the pancreas detected by endoscopic ultrasound and fine-needle aspiration: a case report. BMC Res Notes (2014) 0.75
Bacterial infections in alcoholic and nonalcoholic liver cirrhosis. Eur J Gastroenterol Hepatol (2015) 0.75
Establishing a diagnosis in indeterminate pancreaticobiliary strictures: is confocal laser endomicroscopy the answer? Dig Dis Sci (2012) 0.75
Underutilisation of the gastroscope for total colonoscopy in adults: a survey of two European countries. Int J Colorectal Dis (2012) 0.75
[Difficult to stop primary sclerosing cholangitis]. Lakartidningen (2010) 0.75
Impact of cardiac dysfunction on health-related quality of life in cirrhotic liver transplant candidates. Eur J Gastroenterol Hepatol (2015) 0.75
Spyglass cholangioscopy in the evaluation of an intra-hepatic biliary lesion. Dig Endosc (2011) 0.75
[Helicobacter pylori can in rare cases be the cause of iron and vitamin B 12 deficiency. No increased risk of iron and vitamin B 12 deficiency due to proton pump inhibitors]. Lakartidningen (2004) 0.75
Acute Pancreatitis: Impact of Alcohol Consumption and Seasonal Factors. Alcohol Alcohol (2017) 0.75
Is fatigue related to suppression of hypothalamic-pituitary-adrenal axis activity by bile acids in chronic liver disease? Med Hypotheses (2011) 0.75